Conor signs up St Jude to sell DES (drug-eluting stent) in Japan
This article was originally published in Clinica
Executive Summary
St Jude Medical has gained access to Conor Medsystems' drug-eluting stent (DES) in a distribution deal covering Japan, Korea, Australia and New Zealand. St Jude has provided its new partner with a $5m loan that will convert into Conor shares "in certain circumstances".